NDC 58160-849 – Shingrix
Recombinant Varicella Zoster Virus Glycoprotein E Antigen 50 ug/.5mL · Injection, Solution · Intramuscular
Product NDC58160-849
Product details
- Brand name
- Shingrix
- Generic name
- Zoster Vaccine Recombinant, Adjuvanted
- Labeler
- GlaxoSmithKline Biologicals SA
- Dosage form
- Injection, Solution
- Route
- Intramuscular
- Marketing category
- BLA · BLA125614
- Marketed since
- July 16, 2025
- Listing expires
- December 31, 2027
Active ingredients
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 58160-849-52 | 10 SYRINGE in 1 CARTON (58160-849-52) / .5 mL in 1 SYRINGE (58160-849-43) | Jul 16, 2025 |
Other Shingrix products
- 50090-7919 Recombinant Varicella Zoster Virus Glycoprotein E Antigen 50 ug/.5mL · Injection, Solution · A-S Medication Solutions
- 58160-823 · Kit · GlaxoSmithKline Biologicals SA